Diese Website verwendet Cookies, um das Angebot nutzerfreundlicher und effektiver zu machen. Bitte stimmen Sie der Verwendung von Cookies zu, um alle Funktionen der Website nutzen zu können.Weitere Informationen
SAPORITI CONSULTING operates in veterinarian and human pharmaceuticals; we are specialized in regulatory affairs and formulation development, in Italy as well as abroad, we are able to fulfil the regulatory needs of companies interested in Veterinary use products, Dietetic products, Food supplements, Medical devices, Cosmetics and Medicinal products.
SAPORITI CONSULTING hold the patent and trademark of JPet®-The First Jelly For Pets.
JPet®-The First Jelly For Pets-is an innovative technology, specifically created to obtain a new way of administration in the veterinary field, on board with the most recent marketing trends.
The JPet® characteristic complex matrix is a unique and patented mix of ingredients that allow to contain, in a small 3D patented design Jelly Bone, a large variety of active ingredients, functional to the nutritional supplementation of the pet, permitting the realization of personalized formulation with specific clinical targets.
VETERINARY USE PRODUCTS: regulatory support, development of new formulations (complementary feeds, PARNUTs, hygiene and derma-care products), labelling strategies, borderline product assessment, analytical components assessment, drawing up of technical dossier and advertising material, bibliographic researches.
FOOD SUPPLEMENTS: development of new formulations, labelling development & review, ministerial notification procedures, regulatory consulting, technical dossiers and advertising material, bibliographic researches.
COSMETICS: development of new formulations, labelling development & review, regulatory consulting, technical dossiers and advertising material, bibliographic researches
MEDICAL DEVICES: development of new formulations, regulatory consulting, labelling development & review, technical support, technical dossiers and advertising material, bibliographic researches.